Journal of Blood Medicine
Open access peer-reviewed scientific and medical journals.
Dove Medical Press is now a member of the Open Access Initiative
An Author's Guide
A guide to help authors get their paper published.
Support Open Access and Dove Press
Promotional Article Monitoring - further details
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Preventing stroke in atrial fibrillation patients – clinical utility of oral anticoagulants
(4580) Total Article Views
Authors: Jhawar MB, Flaker G
Published Date April 2012
Volume 2012:3 Pages 1 - 13
|Received:||04 January 2012|
|Accepted:||22 February 2012|
|Published:||12 April 2012|
University of Missouri, Division of Cardiovascular Medicine, Columbia, Missouri, USA
Abstract: Atrial fibrillation is the most common of the cardiac arrhythmias and is associated with high risk of stroke and systemic thromboembolism. Prevention of these complications is therefore a major component of clinical management in patients with this rhythm disorder. The choice of antithrombotic therapy in any given patient depends on his or her risk profile and needs to be carefully balanced against the risk of bleeding. In this review we discuss the pathophysiology of thrombogenesis in atrial fibrillation, risk factors for systemic thromboembolism in atrial fibrillation, patient risk stratification modules both for systemic thromboembolism and the risk of bleeding, current antithrombotic therapy strategies, clinicoepidemiological evidence that led to their evolvement, the challenges that plague them, recent developments in the field and how they could possibly affect our future clinical decision making.
Keywords: atrial fibrillation, systemic thromboembolism, thromboembolism, vitamin K antagonists, oral anticoagulants
Cannotea Citeulike Del.icio.us Facebook LinkedIn Twitter